Results 131 to 140 of about 5,314 (201)

Efficacy and safety of sofosbuvir-based therapies for treating HCV in children: observations from a real-world setting. [PDF]

open access: yesEur J Clin Microbiol Infect Dis
Pokorska-Śpiewak M   +4 more
europepmc   +1 more source

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

open access: yesCost Eff Resour Alloc
Jafari M   +6 more
europepmc   +1 more source

Community-based integrated care for HIV, viral hepatitis and sexually transmitted infections, Thailand. [PDF]

open access: yesBull World Health Organ
Wansom T   +36 more
europepmc   +1 more source

Pharmacokinetics of Sofosbuvir and Velpatasvir for Hepatitis C Treatment in Pregnancy. [PDF]

open access: yesBiomedicines
Giles ML   +7 more
europepmc   +1 more source

Viral hepatitis after liver transplantation: A brief overview. [PDF]

open access: yesWorld J Virol
Praharaj DL   +8 more
europepmc   +1 more source

From the Editor's desk...: July 2016 [PDF]

open access: yes, 2016
Bataller, R   +4 more
core  

Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study. [PDF]

open access: yesBMJ Open
Jafari M   +5 more
europepmc   +1 more source

Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients

open access: yesThe Turkish Journal of Gastroenterology, 2016
Alp Serhat Kahveci, Veysel Tahan
doaj   +1 more source

Home - About - Disclaimer - Privacy